Click for best price
Small Molecule Targeted Cancer Therapy Market Size, Share 2024
This report aims to provide a comprehensive presentation of the global market for Small Molecule Targeted Cancer Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Molecule Targeted Cancer Therapy. This report contains market size and forecasts of Small Molecule Targeted Cancer Therapy in global, including the following market information:
Global Small Molecule Targeted Cancer Therapy Market Revenue, 2019-2024, 2024-2029, ($ millions)
Global top five companies in 2023 (%)
The global Small Molecule Targeted Cancer Therapy market was valued at US$ million in 2023 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Monoclonal Antibodies Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Small Molecule Targeted Cancer Therapy include OncoGenex Pharmaceuticals, Inc., Cytokinetics Inc., Hospira Inc., GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Bayer HealthCare AG and Abbott Laboratories, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Small Molecule Targeted Cancer Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Small Molecule Targeted Cancer Therapy Market, by Type, 2019-2024, 2024-2029 ($ millions)
Global Small Molecule Targeted Cancer Therapy Market Segment Percentages, by Type, 2023 (%)
Monoclonal Antibodies
Small Molecules
Small Molecule Drug Conjugates
Global Small Molecule Targeted Cancer Therapy Market, by Application, 2019-2024, 2024-2029 ($ millions)
Global Small Molecule Targeted Cancer Therapy Market Segment Percentages, by Application, 2023 (%)
Lymphoma
Melanoma
Multiple Myeloma
Breast Cancer
Prostate Cancer
Other Cancers
Global Small Molecule Targeted Cancer Therapy Market, By Region and Country, 2019-2024, 2024-2029 ($ Millions)
Global Small Molecule Targeted Cancer Therapy Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Small Molecule Targeted Cancer Therapy revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Small Molecule Targeted Cancer Therapy revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
OncoGenex Pharmaceuticals, Inc.
Cytokinetics Inc.
Hospira Inc.
GlaxoSmithKline plc
Boehringer Ingelheim GmbH
Bayer HealthCare AG
Abbott Laboratories
Outline of Major Chapters:
Chapter 1: Introduces the definition of Small Molecule Targeted Cancer Therapy, market overview.
Chapter 2: Global Small Molecule Targeted Cancer Therapy market size in revenue.
Chapter 3: Detailed analysis of Small Molecule Targeted Cancer Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Small Molecule Targeted Cancer Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Small Molecule Targeted Cancer Therapy Market, Global Outlook and Forecast 2024-2031 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
63 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Small Molecule Targeted Cancer Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Small Molecule Targeted Cancer Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Small Molecule Targeted Cancer Therapy Overall Market Size
2.1 Global Small Molecule Targeted Cancer Therapy Market Size: 2022 VS 2031
2.2 Global Small Molecule Targeted Cancer Therapy Market Size, Prospects & Forecasts: 2019-2031
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Small Molecule Targeted Cancer Therapy Players in Global Market
3.2 Top Global Small Molecule Targeted Cancer Therapy Companies Ranked by Revenue
3.3 Global Small Molecule Targeted Cancer Therapy Revenue by Companies
3.4 Top 3 and Top 5 Small Molecule Targeted Cancer Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Small Molecule Targeted Cancer Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Small Molecule Targeted Cancer Therapy Players in Global Market
3.6.1 List of Global Tier 1 Small Molecule Targeted Cancer Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Small Molecule Targeted Cancer Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Small Molecule Targeted Cancer Therapy Market Size Markets, 2022 & 2031
4.1.2 Monoclonal Antibodies
4.1.3 Small Molecules
4.1.4 Small Molecule Drug Conjugates
4.2 By Type - Global Small Molecule Targeted Cancer Therapy Revenue & Forecasts
4.2.1 By Type - Global Small Molecule Targeted Cancer Therapy Revenue, 2019-2024
4.2.2 By Type - Global Small Molecule Targeted Cancer Therapy Revenue, 2024-2031
4.2.3 By Type - Global Small Molecule Targeted Cancer Therapy Revenue Market Share, 2019-2031
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Small Molecule Targeted Cancer Therapy Market Size, 2022 & 2031
5.1.2 Lymphoma
5.1.3 Melanoma
5.1.4 Multiple Myeloma
5.1.5 Breast Cancer
5.1.6 Prostate Cancer
5.1.7 Other Cancers
5.2 By Application - Global Small Molecule Targeted Cancer Therapy Revenue & Forecasts
5.2.1 By Application - Global Small Molecule Targeted Cancer Therapy Revenue, 2019-2024
5.2.2 By Application - Global Small Molecule Targeted Cancer Therapy Revenue, 2024-2031
5.2.3 By Application - Global Small Molecule Targeted Cancer Therapy Revenue Market Share, 2019-2031
6 Sights by Region
6.1 By Region - Global Small Molecule Targeted Cancer Therapy Market Size, 2022 & 2031
6.2 By Region - Global Small Molecule Targeted Cancer Therapy Revenue & Forecasts
6.2.1 By Region - Global Small Molecule Targeted Cancer Therapy Revenue, 2019-2024
6.2.2 By Region - Global Small Molecule Targeted Cancer Therapy Revenue, 2024-2031
6.2.3 By Region - Global Small Molecule Targeted Cancer Therapy Revenue Market Share, 2019-2031
6.3 North America
6.3.1 By Country - North America Small Molecule Targeted Cancer Therapy Revenue, 2019-2031
6.3.2 US Small Molecule Targeted Cancer Therapy Market Size, 2019-2031
6.3.3 Canada Small Molecule Targeted Cancer Therapy Market Size, 2019-2031
6.3.4 Mexico Small Molecule Targeted Cancer Therapy Market Size, 2019-2031
6.4 Europe
6.4.1 By Country - Europe Small Molecule Targeted Cancer Therapy Revenue, 2019-2031
6.4.2 Germany Small Molecule Targeted Cancer Therapy Market Size, 2019-2031
6.4.3 France Small Molecule Targeted Cancer Therapy Market Size, 2019-2031
6.4.4 U.K. Small Molecule Targeted Cancer Therapy Market Size, 2019-2031
6.4.5 Italy Small Molecule Targeted Cancer Therapy Market Size, 2019-2031
6.4.6 Russia Small Molecule Targeted Cancer Therapy Market Size, 2019-2031
6.4.7 Nordic Countries Small Molecule Targeted Cancer Therapy Market Size, 2019-2031
6.4.8 Benelux Small Molecule Targeted Cancer Therapy Market Size, 2019-2031
6.5 Asia
6.5.1 By Region - Asia Small Molecule Targeted Cancer Therapy Revenue, 2019-2031
6.5.2 China Small Molecule Targeted Cancer Therapy Market Size, 2019-2031
6.5.3 Japan Small Molecule Targeted Cancer Therapy Market Size, 2019-2031
6.5.4 South Korea Small Molecule Targeted Cancer Therapy Market Size, 2019-2031
6.5.5 Southeast Asia Small Molecule Targeted Cancer Therapy Market Size, 2019-2031
6.5.6 India Small Molecule Targeted Cancer Therapy Market Size, 2019-2031
6.6 South America
6.6.1 By Country - South America Small Molecule Targeted Cancer Therapy Revenue, 2019-2031
6.6.2 Brazil Small Molecule Targeted Cancer Therapy Market Size, 2019-2031
6.6.3 Argentina Small Molecule Targeted Cancer Therapy Market Size, 2019-2031
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Small Molecule Targeted Cancer Therapy Revenue, 2019-2031
6.7.2 Turkey Small Molecule Targeted Cancer Therapy Market Size, 2019-2031
6.7.3 Israel Small Molecule Targeted Cancer Therapy Market Size, 2019-2031
6.7.4 Saudi Arabia Small Molecule Targeted Cancer Therapy Market Size, 2019-2031
6.7.5 UAE Small Molecule Targeted Cancer Therapy Market Size, 2019-2031
7 Small Molecule Targeted Cancer Therapy Companies Profiles
7.1 OncoGenex Pharmaceuticals, Inc.
7.1.1 OncoGenex Pharmaceuticals, Inc. Company Summary
7.1.2 OncoGenex Pharmaceuticals, Inc. Business Overview
7.1.3 OncoGenex Pharmaceuticals, Inc. Small Molecule Targeted Cancer Therapy Major Product Offerings
7.1.4 OncoGenex Pharmaceuticals, Inc. Small Molecule Targeted Cancer Therapy Revenue in Global Market (2019-2024)
7.1.5 OncoGenex Pharmaceuticals, Inc. Key News & Latest Developments
7.2 Cytokinetics Inc.
7.2.1 Cytokinetics Inc. Company Summary
7.2.2 Cytokinetics Inc. Business Overview
7.2.3 Cytokinetics Inc. Small Molecule Targeted Cancer Therapy Major Product Offerings
7.2.4 Cytokinetics Inc. Small Molecule Targeted Cancer Therapy Revenue in Global Market (2019-2024)
7.2.5 Cytokinetics Inc. Key News & Latest Developments
7.3 Hospira Inc.
7.3.1 Hospira Inc. Company Summary
7.3.2 Hospira Inc. Business Overview
7.3.3 Hospira Inc. Small Molecule Targeted Cancer Therapy Major Product Offerings
7.3.4 Hospira Inc. Small Molecule Targeted Cancer Therapy Revenue in Global Market (2019-2024)
7.3.5 Hospira Inc. Key News & Latest Developments
7.4 GlaxoSmithKline plc
7.4.1 GlaxoSmithKline plc Company Summary
7.4.2 GlaxoSmithKline plc Business Overview
7.4.3 GlaxoSmithKline plc Small Molecule Targeted Cancer Therapy Major Product Offerings
7.4.4 GlaxoSmithKline plc Small Molecule Targeted Cancer Therapy Revenue in Global Market (2019-2024)
7.4.5 GlaxoSmithKline plc Key News & Latest Developments
7.5 Boehringer Ingelheim GmbH
7.5.1 Boehringer Ingelheim GmbH Company Summary
7.5.2 Boehringer Ingelheim GmbH Business Overview
7.5.3 Boehringer Ingelheim GmbH Small Molecule Targeted Cancer Therapy Major Product Offerings
7.5.4 Boehringer Ingelheim GmbH Small Molecule Targeted Cancer Therapy Revenue in Global Market (2019-2024)
7.5.5 Boehringer Ingelheim GmbH Key News & Latest Developments
7.6 Bayer HealthCare AG
7.6.1 Bayer HealthCare AG Company Summary
7.6.2 Bayer HealthCare AG Business Overview
7.6.3 Bayer HealthCare AG Small Molecule Targeted Cancer Therapy Major Product Offerings
7.6.4 Bayer HealthCare AG Small Molecule Targeted Cancer Therapy Revenue in Global Market (2019-2024)
7.6.5 Bayer HealthCare AG Key News & Latest Developments
7.7 Abbott Laboratories
7.7.1 Abbott Laboratories Company Summary
7.7.2 Abbott Laboratories Business Overview
7.7.3 Abbott Laboratories Small Molecule Targeted Cancer Therapy Major Product Offerings
7.7.4 Abbott Laboratories Small Molecule Targeted Cancer Therapy Revenue in Global Market (2019-2024)
7.7.5 Abbott Laboratories Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Small Molecule Targeted Cancer Therapy Market Opportunities & Trends in Global Market
Table 2. Small Molecule Targeted Cancer Therapy Market Drivers in Global Market
Table 3. Small Molecule Targeted Cancer Therapy Market Restraints in Global Market
Table 4. Key Players of Small Molecule Targeted Cancer Therapy in Global Market
Table 5. Top Small Molecule Targeted Cancer Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Small Molecule Targeted Cancer Therapy Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Small Molecule Targeted Cancer Therapy Revenue Share by Companies, 2019-2024
Table 8. Global Companies Small Molecule Targeted Cancer Therapy Product Type
Table 9. List of Global Tier 1 Small Molecule Targeted Cancer Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Small Molecule Targeted Cancer Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2022 & 2031
Table 12. By Type - Small Molecule Targeted Cancer Therapy Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Small Molecule Targeted Cancer Therapy Revenue in Global (US$, Mn), 2024-2031
Table 14. By Application ? Global Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2022 & 2031
Table 15. By Application - Small Molecule Targeted Cancer Therapy Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Small Molecule Targeted Cancer Therapy Revenue in Global (US$, Mn), 2024-2031
Table 17. By Region ? Global Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2022 & 2031
Table 18. By Region - Global Small Molecule Targeted Cancer Therapy Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Small Molecule Targeted Cancer Therapy Revenue (US$, Mn), 2024-2031
Table 20. By Country - North America Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2024-2031
Table 22. By Country - Europe Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2024-2031
Table 24. By Region - Asia Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2024-2031
Table 26. By Country - South America Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2024-2031
Table 28. By Country - Middle East & Africa Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2024-2031
Table 30. OncoGenex Pharmaceuticals, Inc. Company Summary
Table 31. OncoGenex Pharmaceuticals, Inc. Small Molecule Targeted Cancer Therapy Product Offerings
Table 32. OncoGenex Pharmaceuticals, Inc. Small Molecule Targeted Cancer Therapy Revenue (US$, Mn) & (2019-2024)
Table 33. OncoGenex Pharmaceuticals, Inc. Key News & Latest Developments
Table 34. Cytokinetics Inc. Company Summary
Table 35. Cytokinetics Inc. Small Molecule Targeted Cancer Therapy Product Offerings
Table 36. Cytokinetics Inc. Small Molecule Targeted Cancer Therapy Revenue (US$, Mn) & (2019-2024)
Table 37. Cytokinetics Inc. Key News & Latest Developments
Table 38. Hospira Inc. Company Summary
Table 39. Hospira Inc. Small Molecule Targeted Cancer Therapy Product Offerings
Table 40. Hospira Inc. Small Molecule Targeted Cancer Therapy Revenue (US$, Mn) & (2019-2024)
Table 41. Hospira Inc. Key News & Latest Developments
Table 42. GlaxoSmithKline plc Company Summary
Table 43. GlaxoSmithKline plc Small Molecule Targeted Cancer Therapy Product Offerings
Table 44. GlaxoSmithKline plc Small Molecule Targeted Cancer Therapy Revenue (US$, Mn) & (2019-2024)
Table 45. GlaxoSmithKline plc Key News & Latest Developments
Table 46. Boehringer Ingelheim GmbH Company Summary
Table 47. Boehringer Ingelheim GmbH Small Molecule Targeted Cancer Therapy Product Offerings
Table 48. Boehringer Ingelheim GmbH Small Molecule Targeted Cancer Therapy Revenue (US$, Mn) & (2019-2024)
Table 49. Boehringer Ingelheim GmbH Key News & Latest Developments
Table 50. Bayer HealthCare AG Company Summary
Table 51. Bayer HealthCare AG Small Molecule Targeted Cancer Therapy Product Offerings
Table 52. Bayer HealthCare AG Small Molecule Targeted Cancer Therapy Revenue (US$, Mn) & (2019-2024)
Table 53. Bayer HealthCare AG Key News & Latest Developments
Table 54. Abbott Laboratories Company Summary
Table 55. Abbott Laboratories Small Molecule Targeted Cancer Therapy Product Offerings
Table 56. Abbott Laboratories Small Molecule Targeted Cancer Therapy Revenue (US$, Mn) & (2019-2024)
Table 57. Abbott Laboratories Key News & Latest Developments
List of Figures
Figure 1. Small Molecule Targeted Cancer Therapy Segment by Type in 2022
Figure 2. Small Molecule Targeted Cancer Therapy Segment by Application in 2022
Figure 3. Global Small Molecule Targeted Cancer Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Small Molecule Targeted Cancer Therapy Market Size: 2022 VS 2031 (US$, Mn)
Figure 6. Global Small Molecule Targeted Cancer Therapy Revenue, 2019-2031 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Small Molecule Targeted Cancer Therapy Revenue in 2022
Figure 8. By Type - Global Small Molecule Targeted Cancer Therapy Revenue Market Share, 2019-2031
Figure 9. By Application - Global Small Molecule Targeted Cancer Therapy Revenue Market Share, 2019-2031
Figure 10. By Type - Global Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2022 & 2031
Figure 11. By Type - Global Small Molecule Targeted Cancer Therapy Revenue Market Share, 2019-2031
Figure 12. By Application - Global Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2022 & 2031
Figure 13. By Application - Global Small Molecule Targeted Cancer Therapy Revenue Market Share, 2019-2031
Figure 14. By Region - Global Small Molecule Targeted Cancer Therapy Revenue Market Share, 2019-2031
Figure 15. By Country - North America Small Molecule Targeted Cancer Therapy Revenue Market Share, 2019-2031
Figure 16. US Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2031
Figure 17. Canada Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2031
Figure 18. Mexico Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2031
Figure 19. By Country - Europe Small Molecule Targeted Cancer Therapy Revenue Market Share, 2019-2031
Figure 20. Germany Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2031
Figure 21. France Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2031
Figure 22. U.K. Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2031
Figure 23. Italy Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2031
Figure 24. Russia Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2031
Figure 25. Nordic Countries Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2031
Figure 26. Benelux Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2031
Figure 27. By Region - Asia Small Molecule Targeted Cancer Therapy Revenue Market Share, 2019-2031
Figure 28. China Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2031
Figure 29. Japan Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2031
Figure 30. South Korea Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2031
Figure 31. Southeast Asia Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2031
Figure 32. India Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2031
Figure 33. By Country - South America Small Molecule Targeted Cancer Therapy Revenue Market Share, 2019-2031
Figure 34. Brazil Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2031
Figure 35. Argentina Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2031
Figure 36. By Country - Middle East & Africa Small Molecule Targeted Cancer Therapy Revenue Market Share, 2019-2031
Figure 37. Turkey Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2031
Figure 38. Israel Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2031
Figure 39. Saudi Arabia Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2031
Figure 40. UAE Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2019-2031
Figure 41. OncoGenex Pharmaceuticals, Inc. Small Molecule Targeted Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Cytokinetics Inc. Small Molecule Targeted Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Hospira Inc. Small Molecule Targeted Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. GlaxoSmithKline plc Small Molecule Targeted Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Boehringer Ingelheim GmbH Small Molecule Targeted Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Bayer HealthCare AG Small Molecule Targeted Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Abbott Laboratories Small Molecule Targeted Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
